Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Aurinia Pharmaceuticals Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +19 vs. Q3 2024
- Shares held
- 58.5M
- −23.8K (0.0%) vs. Q3 2024
- Total value
- $525.4M
- +$96.7M (+22.5%) vs. Q3 2024
- New holders
- 38
- 64 more added
- Sold out
- 19
- 50 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −1,179,740−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −206,099−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −189,955−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −128,013−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −53,327−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −35,532−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −28,452−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −25,392−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −24,230−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −13,823−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,520−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −8,732−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −5,200−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,473−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −1,181−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Spectrum Wealth Counsel, LLC | 0 | $0 | 0.00% | −334−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Banque Cantonale Vaudoise | – | – | – | – | Not filed |